Avanos Medical (AVNS) Operating Income Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.14% |
| Dec 31, 2025 | 15.47% |
| Sep 30, 2025 | 24.57% |
| Jun 30, 2025 | -110.56% |
| Mar 31, 2025 | 76.58% |
| Dec 31, 2024 | -165.04% |
| Sep 30, 2024 | 21.64% |
| Jun 30, 2024 | 21.45% |
| Mar 31, 2024 | 16.68% |
| Dec 31, 2023 | 27.35% |
| Sep 30, 2023 | -29.72% |
| Jun 30, 2023 | -17.49% |
| Mar 31, 2023 | 2.71% |
| Dec 31, 2022 | 49.76% |
| Sep 30, 2022 | 26.43% |
| Jun 30, 2022 | 23.17% |
| Mar 31, 2022 | 20.00% |
| Dec 31, 2021 | 33.99% |
| Sep 30, 2021 | -30.45% |
| Jun 30, 2021 | -19.28% |
| Mar 31, 2021 | -18.88% |
| Dec 31, 2020 | -16.86% |
| Sep 30, 2020 | 81.50% |
| Jun 30, 2020 | -15.79% |
| Mar 31, 2020 | -57.02% |
| Dec 31, 2019 | -16.36% |
| Sep 30, 2019 | -27.59% |
| Jun 30, 2019 | -16.84% |
| Mar 31, 2019 | -19.12% |
| Dec 31, 2018 | -16.48% |
| Sep 30, 2018 | -36.96% |